How often should levetiracetam (Keppra) and lamotrigine (Lamictal) serum levels be checked in a patient with epilepsy?

Routine Therapeutic Drug Monitoring of Levetiracetam and Lamotrigine Levels is Generally Not Necessary in Stable Epilepsy Patients

For most patients with epilepsy on Keppra (levetiracetam) or Lamictal (lamotrigine), routine scheduled monitoring of drug levels is not recommended. These medications do not require regular therapeutic drug monitoring in the same way older antiepileptic drugs do, as there is no established correlation between serum levels and either efficacy or toxicity for routine clinical management.

When to Check Levels: A Targeted Approach

Rather than routine scheduled monitoring, drug levels should be checked in specific clinical situations:

Situations Warranting Level Monitoring:

• Breakthrough seizures despite previously good control
• Suspected non-adherence to medication regimen
• Pregnancy - particularly important as both drugs show significantly decreased levels throughout gestation 1, 2
  • Levetiracetam levels decline by the second half of first trimester and remain reduced throughout pregnancy 1
  • Lamotrigine levels decrease significantly in the first half of first trimester and stay low throughout pregnancy 1
• Drug-resistant epilepsy - these patients warrant closer monitoring given higher seizure risk 1
• Special populations with altered pharmacokinetics:
  • Elderly patients (levetiracetam clearance decreased by almost 50%) 2
  • Pediatric patients (levetiracetam clearance increased by 30-40%) 2
  • Critically ill patients (augmented clearance requiring higher doses) 2
  • Renal impairment or dialysis patients 2
• Addition or removal of enzyme-inducing medications (carbamazepine, phenytoin, phenobarbital) 3, 4
• Addition or removal of valproate (significantly affects lamotrigine levels) 4
• Suspected toxicity or adverse effects

Why Routine Monitoring Isn't Beneficial

The evidence is clear on this point:

• No positive correlation exists between levetiracetam levels and efficacy or toxicity - variable levels are reported with adverse effects, seizures, and efficacy occurring below, within, and above supposed reference ranges 2
• Lamotrigine levels and efficacy show incomplete correlation - no precise therapeutic range can be defined based solely on blood levels and seizure frequency 5
• A 2023 study specifically examining pregnant women found that frequency and timing of drug level monitoring did not affect overall seizure outcomes during pregnancy for patients on lamotrigine or levetiracetam 1

Practical Monitoring Strategy

Baseline Approach:

1. Establish an individual therapeutic level when the patient is stable and seizure-free
2. Use this as the patient's personal reference point for future comparisons
3. Check levels only when clinical circumstances change (see situations above)

Drug Interactions to Monitor:

• Levetiracetam with enzyme inducers: Median clearance is 1.3-fold higher, resulting in lower trough levels (10.4 vs 14.7 μg/mL) 3
• Lamotrigine with valproate: Requires half the usual dose due to inhibited clearance 4
• Lamotrigine with enzyme inducers: Requires double the usual dose 4

Pregnancy-Specific Considerations:

• While earlier studies suggested frequent monitoring, recent evidence 1 indicates that preemptive dose adjustments work as well as laboratory-based management for lamotrigine
• Exception: Patients with drug-resistant epilepsy before pregnancy need earlier and closer monitoring given high risk of first-trimester seizures 1
• Postpartum: Empiric dose tapering protocols (at days 1,7, and 21) are safe and effective without requiring intensive monitoring 6

Common Pitfalls to Avoid

1. Don't treat numbers instead of patients - a "low" level in an asymptomatic, seizure-free patient doesn't require intervention
2. Don't assume therapeutic ranges from older antiepileptic drugs apply - these medications have different pharmacology
3. Don't forget to account for concomitant medications when interpreting levels 3, 4
4. Don't delay checking levels when seizures break through - this is when levels are actually useful

The bottom line: Check levels when clinical circumstances change, not on a predetermined schedule. 2, 3